Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-06

FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Original Application (SpecGx LLC)

View source ↗

Summary

FDA approved the original application for Diphenoxylate hydrochloride and atropine sulfate (SpecGx LLC). This is a generic antidiarrheal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenoxylate hydrochloride and atropine sulfate (Diphenoxylate hydrochloride and atropine sulfate)

Snippet

ORIG AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)